Usefulness and Safety of Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy

American Journal of Cardiology

Volumn 99, Issue 11, 2007, Pages 1575-1581

  Gaita, Fiorenzo ^a   Di Donna, Paolo ^a   Olivotto, Iacopo ^b   Scaglione, Marco ^a   Ferrero, Ivana ^a   Montefusco, Antonio ^a   Caponi, Domenico ^a   Conte, Maria Rosa ^c   Nistri, Stefano ^b   Cecchi, Franco ^b  

^a Ospedale Cardinal Massaia   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c OSPEDALE DEGLI INFERMI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; FLECAINIDE; PROPAFENONE; QUINIDINE; SOTALOL;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART VOLUME; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; ONSET AGE; PRIORITY JOURNAL; PULMONARY VEIN; RECURRENT DISEASE; SAFETY; SINUS RHYTHM; STROKE; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FUNCTION; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY, AMBULATORY; EQUIPMENT SAFETY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; ITALY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34248670679     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.12.087     Document Type: Article

References (25)

1. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., Shah P.M., Spencer III W.H., Spirito P., Ten Cate F.J., Wigle E.D., and Task Force on Clinical Expert Consensus Documents. American College of Cardiology, Committee for Practice Guidelines, European Society of Cardiology, American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 (2003) 1687-1713
2. Maron B.J., Olivotto I., Bellone P., Conte M.R., Cecchi F., Flygenring B.P., Casey S.A., Gohman T.E., Bongioanni S., and Spirito P. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 39 (2002) 301-307
3. Olivotto I., Cecchi F., Casey S.A., Dolara A., Traverse J.H., and Maron B.J. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104 (2001) 2517-2522
4. Glancy D.L., O'Brien K.P., Gold H.K., and Epstein S.E. Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis. Br Heart J 32 (1970) 652-659
5. Stafford W.J., Trohman R.G., Bilsker M., Zaman L., Castellanos A., and Myerburg R.J. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 7 (1986) 701-704
6. Furlan A.J., Craciun A.R., Raju N.R., and Hart N. Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis. Stroke 15 (1984) 282-284
7. Fuster V., Ryden L.E., Asinger R.W., Cannom D.S., Crijins H.J., Frye R.L., Halperin J.L., Kay G.N., Klein W.W., Levy S., et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines, European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation), North American Society of Pacing and Electrophysiology. Circulation 104 (2001) 2118-2150
8. Wyse D.G., Waldo A.L., DiMarco J.P., Domanski M.J., Rosenberg Y., Schron E.B., Kellen J.C., Greene H.L., Mickel M.C., Dalquist J.E., Corley S.D., and Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. :a comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
9. Haissaguerre M., Jais P., Shah D.C., Takahashi A., Hocini M., Quiniou G., and Garrigue S. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339 (1998) 659-666
10. Haissaguerre M., Jais P., Shah D.C., Garrigue S., Takahashi A., Lavergne T., Hocini M., Peng J.T., Roudaut R., Clementy J., et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 101 (2000) 1409-1417
11. Oral H., Scharf C., Chugh A., Hall B., Cheung P., Good E., Veerareddy S., Pelosi Jr. F., and Morady F. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 108 (2003) 2355-2360
12. Liu X., Ouyang F., Mavrakis H., Ma C., Dong J., Ernst S., Bansch D., Antz M., and Kuck K.H. Complete pulmonary vein isolation guided by three-dimensional electroanatomical mapping for the treatment of paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. Europace 7 (2005) 421-427
13. Kilicaslan F., Verma A., Saad E., Themistoclakis S., Bonso A., Raviele A., Bozbas H., Andrews M.W., Beheiry S., Hao S., et al. Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. Heart Rhythm 3 (2006) 275-280
14. Gaita F., Riccardi R., Caponi D., Shah D., Garberoglio L., Vivalda L., Dulio A., Chiecchio A., Manasse E., and Gallotti R. Linear cryoablation of the left atrium versus pulmonary vein cryoisolation in patients with permanent atrial fibrillation and valvular heart disease: correlation of electroanatomic mapping and long-term clinical results. Circulation 111 (2005) 136-142
15. Klues H.G., Schiffers A., and Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26 (1995) 1699-1708
16. McKenna W.J., Spirito P., Desnos M., Dubourg O., and Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 77 (1997) 130-132
17. Jais P., Hocini M., Hsu L.F., Sanders P., Scavee C., Weerasooriya R., Macle L., Raybaud F., Garrigue S., Shah D.C., et al. Technique and results of linear ablation at the mitral isthmus. Circulation 110 (2004) 2996-3002
18. Hocini M., Jais P., Sanders P., Takahashi Y., Rotter M., Rostock T., Hsu L.F., Sacher F., Reuter S., Clementy J., and Haissaguerre M. Techniques, evaluation and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation. A prospective randomized study. Circulation 112 (2005) 3688-3696
19. Oral H., Knight P., Ozaydin M., Tada H., Chugh A., Hassan S., Scharf C., Lai S.W.K., Greenstein R., Pelosi F., Strickberger A., and Morady F. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. J Am Coll Cardiol 40 (2002) 100-104
20. Wijffels M.C., Kirchhof C.J., Dorland R., and Allessie M.A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92 (1995) 1954-1968
21. Cecchi F., Olivotto I., Montereggi A., Santoro G., Dolara A., and Maron B.J. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected population. J Am Coll Cardiol 26 (1995) 1529-1536
22. Chen M.S., McCarthy P.M., Lever H.M., Smedira N.G., and Lytle B.L. Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy. Am J Cardiol 93 (2004) 373-375
23. Cappato R., Calkins H., Chen S.A., Davies W., Iesaka Y., Kalman J., Kim Y.H., Klein G., Packer D., and Skanes A. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111 (2005) 1100-1105
24. Hsu L.F., Jais P., Sanders P., Garrigue S., Hocini M., Sacher F., Takahashi Y., Rotter M., Pasquie J.L., Scavee C., et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351 (2004) 2373-2383
25. Lang C.C., Santinelli V., Augello G., Ferro A., Gugliotta F., Gulletta S., Vicedomini G., Mesas C., Paglino G., Sala S., et al. Transcatheter radiofrequency ablation of atrial fibrillation in patients with mitral valve prostheses and enlarged atria: safety, feasibility, and efficacy. J Am Coll Cardiol 45 (2005) 868-872